Who to refer

  • Any patient receiving maintenance oral corticosteroids for asthma (> 3 weeks course)

  • Or  ≥3 exacerbations in previous 12 months

  Make an urgent referral for any patient on moderate dose MART with >/= 3 exacerbations with EoS >3 or FeNO > 30

Who not to refer

  • Patients who do not have severe asthma as per the criteria set out

How to refer

  • SCI Gateway/Respiratory/Airways Disease 

Alternative to Referral

Advice available through SCI-Gateway as above


Condition Description

Severe persistent asthma characterised by frequent symptoms despite high-dose inhaled corticosteroids and additional controller therapy. The patient experiences recurrent exacerbations requiring oral corticosteroids, has reduced lung function (FEV₁ <80% predicted), and significant impact on daily activities. Ongoing symptoms include wheezing, breathlessness, and nocturnal cough. Triggered by allergens, viral infections, and environmental irritants.


Primary Care Investigation

Management is as per nhs-scotland-severe-asthma-pathway-february-2026.pdf

As per flow chart:

  • Identify patients at risk of severe asthma

  • Optimise current therapy for the patient

  • Assess for reversible factors


Primary Care Management

Management is as per nhs-scotland-severe-asthma-pathway-february-2026.pdf

As per flow chart:

  • Maintain therapy  

  • Schedule asthma (face to face) review


Useful resources

Expand this content